GTR 113197138
Quotation Are Invited For Risankizumab 360 Mg/2.4 Ml (150 Mg/Ml) Subcutaneous Wearable Injector
ICB — International Competitive Bid
Closed
Asia
Tender Information
GTR Reference
113197138
Tendering Authority
Subscribe to view
Tender No
srfq_241274
Financer Name
Self-Funded
Work Title
Quotation Are Invited For Risankizumab 360 Mg/2.4 Ml (150 Mg/Ml) Subcutaneous Wearable Injector
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Asia
Political Region
Arab World1,Gulf Cooperation Council, GCC,Middle East,Middle East and North Africa, MENA
Last Date of Bid Submission
20-05-2026
Closed
Work Detail
Quotation are invited for Risankizumab 360 Mg/2.4 Ml (150 Mg/Ml) Subcutaneous Wearable Injector Description: 1: [520-24217] RISANKIZUMAB 360 MG/2.4 ML (150 MG/ML) SUBCUTANEOUS WEARABLE INJECTOR.- - 200 EA Online Response Required: Yes Closing: 20/05/2026 10:00:00 Time Limit for Expressing Interest: 20/05/2026 10:00:00 In order to participate in this RFQ/Tender, please register online on www.eSupply.dubai.gov.ae, which is the official procurement portal of Dubai Government. Supplier Registration: https://esupply.dubai.gov.ae/esop/guest/go/public/registration?locale=en_GB&country=AE&customGuest= Tender Link : https://esupply.dubai.gov.ae/esop/toolkit/opportunity/current/240864/detail.si
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
b5d9b1ce-30fa-4f91-b095-311ce10bd1a7.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.